TrialCard

TrialCard

TrialCard Market Access Solutions provide pharmaceutical marketing services.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

€0.0

round
investor

€0.0

round
*

N/A

Acquisition
Total Funding000k
Notes (0)
More about TrialCard
Made with AI
Edit

TrialCard is a technology-driven pharmaceutical solutions company focused on enhancing the experiences of patients and providers. Operating in the life sciences sector, TrialCard serves pharmaceutical manufacturers by offering an integrated suite of solutions designed to simplify access to medications and improve patient outcomes. The company connects patients with branded drug savings, having facilitated over $22 billion in savings for more than 35 million patients to date. TrialCard's business model revolves around providing comprehensive, digitally enabled solutions that span the entire value chain, from patient access and support to provider engagement and payer interactions. Revenue is generated through service fees from pharmaceutical manufacturers who seek to improve patient access to their medications and streamline the commercialization process. TrialCard's market includes pharmaceutical companies, healthcare providers, payers, and pharmacies, all of whom benefit from the company's innovative approach to patient care and medication access.

Keywords: pharmaceutical solutions, patient access, provider engagement, drug savings, life sciences, integrated services, digital solutions, healthcare, commercialization, medication access.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by TrialCard

Edit
Mango Health
ACQUISITION by TrialCard Sep 2019
Triangle Insights Group
ACQUISITION by TrialCard Apr 2022
Canary Insights
ACQUISITION by TrialCard Oct 2020
Archer Healthcare
ACQUISITION by TrialCard Nov 2021